Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more
Inspire Medical Systems Inc (INSP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.067x
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has a cash flow conversion efficiency ratio of 0.067x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($52.47 Million) by net assets ($781.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inspire Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inspire Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inspire Medical Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság
F:MGYB
|
0.137x |
|
Apollo Tyres Limited
NSE:APOLLOTYRE
|
0.085x |
|
Atlantica Sustainable Infrastructure PLC
NASDAQ:AY
|
0.118x |
|
S&T Bancorp Inc
NASDAQ:STBA
|
0.028x |
|
Procept Biorobotics Corp
NASDAQ:PRCT
|
-0.017x |
|
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
NASDAQ:PSNYW
|
0.058x |
|
Shaanxi Energy Investment Co Ltd. A
SHE:001286
|
0.083x |
|
Milbon Co. Ltd
PINK:MIOFF
|
0.022x |
Annual Cash Flow Conversion Efficiency for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Inspire Medical Systems Inc from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $781.16 Million | $116.98 Million | 0.150x | -20.70% |
| 2024-12-31 | $689.70 Million | $130.25 Million | 0.189x | +338.55% |
| 2023-12-31 | $572.51 Million | $24.65 Million | 0.043x | +84.62% |
| 2022-12-31 | $496.01 Million | $11.57 Million | 0.023x | +126.55% |
| 2021-12-31 | $229.05 Million | $-20.12 Million | -0.088x | +61.96% |
| 2020-12-31 | $229.75 Million | $-53.05 Million | -0.231x | +3.27% |
| 2019-12-31 | $139.84 Million | $-33.38 Million | -0.239x | -109.40% |
| 2018-12-31 | $164.00 Million | $-18.69 Million | -0.114x | +98.93% |
| 2017-12-31 | $1.48 Million | $-15.79 Million | -10.641x | -491.75% |
| 2016-12-31 | $-6.61 Million | $-17.95 Million | 2.716x | -- |